4.4 Article

Perfluorooctanoate exposure and major birth defects

Journal

REPRODUCTIVE TOXICOLOGY
Volume 47, Issue -, Pages 15-20

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.reprotox.2014.04.006

Keywords

Congenital abnormalities; Epidemiology; Fluorocarbons; Perfluorooctanoic acid

Funding

  1. C8
  2. E.I. du Pont de Nemours Company [01-C-608]
  3. Wood County Circuit Court, West Virginia, USA
  4. DuPont
  5. National Institute of Environmental Health Sciences [K01 ES019156]

Ask authors/readers for more resources

Perfluorooctanoate (PFOA) is detectable in umbilical cord blood and amniotic fluid. Some toxicological findings suggest that perfluoroalkyl substances may be teratogenic. Using data from the C8 Health Project, a 2005-2006 survey in a Mid-Ohio Valley community exposed to PFOA through contaminated drinking water, we examined the association between estimated prenatal PFOA concentration and maternally reported birth defects (n = 325) among 10,262 live singleton or multiple births from 1990 to 2006. Logistic regression models accounted for siblings using generalized estimating equations. There was generally no association between estimated PFOA concentration and birth defects, with the possible exception of brain defects, where the odds ratio adjusted for year of conception was 2.6 (95% confidence interval 1.3-5.1) for an increase in estimated PFOA exposure from the 25th to 75th percentile. This estimate, however, was based on 13 cases and may represent a chance finding. Further investigation of this potential association may be warranted. (C) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available